Biodexa Pharmaceuticals PLC-ADR (5MP2) Stock Price & News

All values in GBP	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	-	-	-	-
Cost of goods sold	832.50K	832.50K	1.15M	1.15M
Cost of revenue	832.50K	832.50K	1.15M	1.15M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.19M	1.19M	1.23M	1.23M
Operating expense	1.18M	1.18M	1.17M	1.17M
Total operating expenses	2.01M	2.01M	2.31M	2.31M
Operating income	-2.01M	-2.01M	-2.31M	-2.31M
Other non operating income	72.50K	72.50K	1.08M	1.08M
EBT including unusual items	-1.99M	-1.99M	-1.26M	-1.26M
EBT excluding unusual items	-1.99M	-1.99M	-1.26M	-1.26M
Income tax expense	-82.50K	-82.50K	30.00K	30.00K
Effective tax rate	4.16%	4.16%	-2.38%	-2.38%
Other operating expenses	-13.50K	-13.50K	-62.50K	-62.50K
Net income	-1.90M	-1.90M	-1.29M	-1.29M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	17.50K	17.50K	27.00K	27.00K
Interest expense	-67.50K	-67.50K	-47.00K	-47.00K
Net interest expenses	-50.00K	-50.00K	-20.00K	-20.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.97M	-1.97M	-2.29M	-2.30M
Gain or loss from assets sale	-	-	14.50K	14.50K

Finance